Atlas Trials

Registry of Guardant360® Use and Outcomes In People With Advanced Cancer

Clinical trial NCT03477474 · TERMINATED

Trial details

NCT number
NCT03477474
Sponsor
Guardant Health, Inc.
Status
TERMINATED
Study type
OBSERVATIONAL
Non-small Cell Lung Cancer Metastatic
Start date
2018-04-06
Primary completion
2019-09-01
Enrollment
311

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.